未登录
分享
收藏
分享
收藏Phase I dose-finding and pharmacokinetic trial of irinotecan (CPT-11) administered every two weeks
Rothenberg, ML; Kuhn, JG; Schaaf, LJ; Rodriguez, GI; Eckhardt, SG; Villalona-Calero, MA; Rinaldi, DA; Hammond, LA; Hodges, S; Sharma, A; Elfring, GL; Petit, RG; Locker, PK; Miller, LL; von Hoff, DD
分享
收藏
分享
收藏